Investment Funds Managed by Golden Gate Capital Complete Acquisition of ANGUS Chemical Company

SAN FRANCISCO & BUFFALO GROVE, Ill - Feb 03, 2015 (BUSINESS WIRE)

Golden Gate Capital, a private equity investment firm with more than $12 billion of committed capital under management, today announced that investment funds managed by Golden Gate Capital have successfully completed the acquisition of ANGUS Chemical Company (ANGUS), the world’s only chemical company dedicated to the manufacture and distribution of nitroalkanes and their derivatives, from The Dow Chemical Company DOW, +2.41%.

ANGUS will continue to be led by its current senior management team, including President and CEO Mark A. Henning. Additionally, ANGUS will continue to honor all customer, licensing and supplier contracts and related agreements.

“We strongly support ANGUS management and believe their strategic vision for the Company will drive long-term success,” said Rajeev Amara, Managing Director at Golden Gate Capital. “Looking ahead, we are focused on working with the ANGUS team to invest in targeted growth areas through their Customer Application Centers as well as in their people, capacity, and next generation R&D pipeline.”

“While our ownership has changed, our commitment to our customers remains stronger than ever,” said Mark A. Henning, ANGUS President and CEO. “We look forward to working with our new partners to continue our positive momentum in the marketplace – driving growth at the local level by constantly proving how ANGUS chemistry helps our customers’ products and processes perform better.”

As previously announced, the $1.215 billion transaction includes the ANGUS business headquarters and R&D facility in Buffalo Grove, IL; manufacturing facilities located in Sterlington, LA, and Ibbenbueren, Germany; a life-science additive facility in Niagara Falls, NY; as well as the associated business, inventory, customer contracts, process technology, business know-how and certain intellectual property.


About ANGUS Chemical Company

ANGUS Chemical Company (“ANGUS”) is a specialty amine company dedicated to the development of novel chemistry that helps customers deliver enhanced product and process performance. ANGUS is committed to constantly improving products and services by mastering science and technology. The company innovates through its unique nitroalkane chemistry, which harbors the reactivity to create complex molecules for use in a wide variety of applications. The innate characteristics of this chemistry enable multifunctional additives which improve performance, reduce reaction steps and cut synthesis costs.


About Golden Gate Capital

Golden Gate Capital is a San Francisco-based private equity investment firm with approximately $12 billion of capital under management. Golden Gate Capital is dedicated to partnering with world-class management teams to invest in change-intensive, growth businesses. The firm targets investments where there is a demonstrable opportunity to significantly enhance a company’s value. The principals of Golden Gate Capital have a long and successful history of investing with management partners across a wide range of industries and transaction types. Other notable mining and industrials investments sponsored by Golden Gate Capital include US Silica, EP Minerals, ArrMaz, Humanetics Innovative Solutions, Springs Window Fashions, Canada Fluorspar Inc. and Atrium Windows. For more information, visit www.goldengatecap.com.


Media for ANGUS Chemical Company:

Please email media@angus.com or call our headquarters in Buffalo Grove, IL at (844) 474-9969.


Media for Golden Gate Capital:

Sard Verbinnen & Co
Nathaniel Garnick / Jenny Gore
212-687-8080 / 312-895-4700